Related Experiment Video
Updated: Jun 15, 2026

Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells
Published on: July 27, 2018
The efficient generation of functional human hepatocytes from chemically induced pluripotent stem cells
Yun Lv1, Ziyan Rao2,3, Lulu Liu4
1School of Basic Medical Sciences, MOE Engineering Research Center of Regenerative Medicine, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center and the MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
Researchers developed an efficient method to generate human hepatic progenitor cells and hepatocytes from chemically induced pluripotent stem cells (hCiPSCs). This new protocol mimics natural liver development, paving the way for cell therapy and drug discovery applications.
Area of Science:
- Stem cell biology
- Hepatology
- Developmental biology
Background:
- Deriving human hepatocytes from pluripotent stem cells is crucial for cell therapy and drug discovery.
- Current in vitro differentiation methods do not accurately mimic natural liver development.
Purpose of the Study:
- To develop an efficient protocol for generating hepatic progenitor cells and hepatocytes from chemically induced pluripotent stem cells (hCiPSCs).
- To mimic the two-stage developmental process of hepatoblasts for improved differentiation efficiency.
Main Methods:
- Chemically induced pluripotent stem cells (hCiPSCs) were used for differentiation.
- A two-stage protocol mimicking hepatoblast development was implemented.
- Single-cell RNA sequencing (scRNA-seq) was employed to analyze cell populations.
Main Results:
- The protocol efficiently generated hepatic progenitor cells from hCiPSCs.
- scRNA-seq confirmed the similarity of in vitro-derived hepatoblasts to their in vivo counterparts.
- hCiPSC-derived hepatic progenitor cells differentiated into hepatocytes with gene expression and functions comparable to primary human hepatocytes.
Conclusions:
- This study demonstrates a feasible and efficient method for generating hepatic progenitor cells and hepatocytes from hCiPSCs.
- The developed protocol successfully recapitulates key aspects of in vivo liver development.
- These findings provide a foundation for the translational application of hCiPSC-derived hepatocytes in regenerative medicine and drug development.

